← FDA DRUG APPROVALS

FDA ANDA · ANDA076653

FLUCONAZOLE IN SODIUM CHLORIDE 0.9%

Sponsor: DR REDDYS

APPLICATION
ANDA076653
TYPE
ANDA
ORIGINAL APPROVAL
2004-07-29
LATEST ACTION
2024-12-09
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

FLUCONAZOLE IN SODIUM CHLORIDE 0.9%Discontinued
FLUCONAZOLE 400MG/200ML (2MG/ML) · INJECTABLE · INJECTION
FLUCONAZOLE IN SODIUM CHLORIDE 0.9%Discontinued
FLUCONAZOLE 200MG/100ML (2MG/ML) · INJECTABLE · INJECTION

Approval history

2024-12-09Labeling · Supplement 24 · standardAP
2024-12-09Labeling · Supplement 22 · standardAP
2024-12-09Labeling · Supplement 25 · standardAP
2024-12-09Labeling · Supplement 23 · standardAP
2013-01-29Labeling · Supplement 13AP
2009-11-16Labeling · Supplement 3AP
2004-07-29OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →